Patients with T1D (n=47,720) or T2D (n=686,158) in 2005 to 2019 ... “Further research is needed to better understand the mechanisms behind the increased hemorrhagic stroke risk in type 1 ...

New research suggests that there may be significant differences in kidney disease among individuals with type 1 diabetes (T1D) vs those with type 2 diabetes (T2D), potentially influencing the risk ...

Research to gain a clearer understanding of the mechanisms ... we discuss the epidemiological, pathophysiological and genetic links between diabetes (both T2D and Type 1 diabetes mellitus [T1D ...

T1D Exchange, a nonprofit organization that drives meaningful research and improvement in care and outcomes in type 1 diabetes (T1D) and type 2 diabetes (T2D), today announced that new research ...

While major advances in drug treatment have been made for Type 2 diabetes (T2D) and the often-associated obesity, Shalev points out in her review that there are still no approved and effective ...

The study population included 5,823 T1D patients and 156,204 T2D patients over 758,643 visits to outpatient primary care or endocrinology facilities. Participants were aged 46 to 75.

Type 1.5 diabetes is commonly known as LADA, or latent autoimmune diabetes in adults. This type of diabetes shares characteristics of both type 1 (T1D) and type 2 (T2D) diabetes.

Western Sydney University researchers have led a global team to pioneer a new AI-powered tool to assess the risk of developing type 1 diabetes (T1D) and predict treatment responses, potentially ...

Most of those people have T2D, while only about 10% have T1D. Beyond those with diabetes, 1 in 3 people in the United States have prediabetes.

Specifically, her group found that for T2D versus T1D (P<0.001 for both): LOS: 3.81 vs 2.97 days; Hospital charges: Average $40,433 vs $29,873 ...

According to the findings from studies involving the technology, significant glycaemic improvements were observed in subjects with T1D. The latest FDA approval for T2D use is based on outcomes ...